CLEVELAND, July 5, 2011 /PRNewswire/ -- RSB Spine, LLC, a medical device company focused on developing unique modular fusion products for surgical treatment of degenerative disc disease, today announced a 131% sales increase for the second quarter of 2011 versus second quarter 2010, and a 20% increase sequentially. These record results represent the seventh consecutive sequential period of quarterly growth for the company.
RSB Spine Chief Executive Officer John A. Redmond said: "Our performance this quarter is especially gratifying given the challenges facing the spinal implant market, with price erosion and reimbursement pushback from insurance companies. It is a testament to our superior product offering and distribution."
"We are very excited with the rapid expansion of our product portfolio. We are now the first and only company to offer an allograft flush-fit technology," said Mike O'Neill, CEO of Paradigm BioDevices. "Our surgeon customers are very excited by the unique options these modular implants offer their patients, reinforcing our continuing portfolio expansion."
RSB Spine is a privately held medical device company. News releases and other information on the company are available on the Internet at: http://www.rsbspine.com.
Paradigm BioDevices, Inc. is a privately held Boston-based medical device distributor. News releases and other information on the company are available at www.paradigmbiodevices.com.
SOURCE RSB Spine, LLC